In fact, when 1,000 patients with advanced cancer were studied using exome sequencing of a 202‐gene panel, 151 patients showed germline variants and 15 patients had pathogenic germline variants, including two cases with CDH1 mutations (You et al., 2019). Here, CDH1 is linked to cancer.